Duration of Anticoagulant Therapy and VTE Recurrence in Patients With Cancer

Supportive Care in Cancer - Germany
doi 10.1007/s00520-019-4661-3
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Combined Aspirin and Anticoagulant Therapy in Patients With Atrial Fibrillation

Journal of Thrombosis and Thrombolysis
Cardiovascular MedicineHematologyCardiology
2016English

Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia

Circulation
Cardiovascular MedicinePhysiologyCardiology
2001English

Risk Assessment and Prophylaxis for VTE in Cancer Patients

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2011English

Preventing VTE in Outpatients With Cancer

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2012English

Implication of Duration of Clinical Presentation on Tumor Progression and Short-Term Recurrence in Patients With Early Breast Cancer

Molecular and Clinical Oncology
Cancer ResearchOncology
2015English

Individualising Anticoagulant Therapy in Atrial Fibrillation Patients

Arrhythmia and Electrophysiology Review
Cardiovascular MedicinePhysiologyCardiology
2016English

Apixaban Therapy Is Effective and Safe for Cancer-Associated VTE

Nature Reviews Cardiology
Cardiovascular MedicineCardiology
2020English

Anticoagulant Therapy in Patients With Chronic Lymphocytic Leukemia Receiving Ibrutinib

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Educational and Behavioural Interventions for Anticoagulant Therapy in Patients With Atrial Fibrillation

2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy